226 related articles for article (PubMed ID: 36032031)
1. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation.
Nelson J; Alvey N; Bowman L; Schulte J; Segovia MC; McDermott J; Te HS; Kapila N; Levine DJ; Gottlieb RL; Oberholzer J; Campara M
Pharmacotherapy; 2022 Aug; 42(8):599-633. PubMed ID: 36032031
[TBL] [Abstract][Full Text] [Related]
2. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and International Society for Heart and Lung Transplantation: An executive summary.
Nelson J; Alvey N; Bowman L; Schulte J; Segovia MC; McDermott J; Te HS; Kapila N; Levine DJ; Gottlieb RL; Oberholzer J; Campara M
Pharmacotherapy; 2022 Aug; 42(8):594-598. PubMed ID: 35810342
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression in solid organ-transplant recipients and impact on nutrition support.
Wilson NK; Kataria AD
Nutr Clin Pract; 2024 Feb; 39(1):109-116. PubMed ID: 38030572
[TBL] [Abstract][Full Text] [Related]
4. Evolving immunosuppressive regimens for lung transplant recipients.
Meyer NJ; Bhorade SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression in Lung Transplantation.
Nelson J; Kincaide E; Schulte J; Hall R; Levine DJ
Handb Exp Pharmacol; 2022; 272():139-164. PubMed ID: 34796380
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression in the pediatric transplant recipient.
Blondet NM; Healey PJ; Hsu E
Semin Pediatr Surg; 2017 Aug; 26(4):193-198. PubMed ID: 28964473
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus: a further update of its use in the management of organ transplantation.
Scott LJ; McKeage K; Keam SJ; Plosker GL
Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression for lung transplantation.
Bhorade SM; Stern E
Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression considerations in simultaneous organ transplant.
Kovac D; Choe J; Liu E; Scheffert J; Hedvat J; Anamisis A; Salerno D; Lange N; Jennings DL
Pharmacotherapy; 2021 Jan; 41(1):59-76. PubMed ID: 33325558
[TBL] [Abstract][Full Text] [Related]
11. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F
Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508
[TBL] [Abstract][Full Text] [Related]
12. Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier.
Ensor CR; Goehring KC; Iasella CJ; Moore CA; Lendermon EA; McDyer JF; Morrell MR; Sciortino CM; Venkataramanan R; Wiland AM
Clin Transplant; 2018 Oct; 32(10):e13363. PubMed ID: 30058177
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Brunet M; van Gelder T; Åsberg A; Haufroid V; Hesselink DA; Langman L; Lemaitre F; Marquet P; Seger C; Shipkova M; Vinks A; Wallemacq P; Wieland E; Woillard JB; Barten MJ; Budde K; Colom H; Dieterlen MT; Elens L; Johnson-Davis KL; Kunicki PK; MacPhee I; Masuda S; Mathew BS; Millán O; Mizuno T; Moes DAR; Monchaud C; Noceti O; Pawinski T; Picard N; van Schaik R; Sommerer C; Vethe NT; de Winter B; Christians U; Bergan S
Ther Drug Monit; 2019 Jun; 41(3):261-307. PubMed ID: 31045868
[TBL] [Abstract][Full Text] [Related]
14. [Modern immunosuppression after solid organ transplantation].
Beimler J; Morath C; Zeier M
Internist (Berl); 2014 Feb; 55(2):212-22. PubMed ID: 24518922
[TBL] [Abstract][Full Text] [Related]
15. Pediatric heart and lung transplantation.
Reddy SC; Webber SA
Indian J Pediatr; 2003 Sep; 70(9):723-9. PubMed ID: 14620188
[TBL] [Abstract][Full Text] [Related]
16. Heart and lung transplantation in children.
Webber SA; McCurry K; Zeevi A
Lancet; 2006 Jul; 368(9529):53-69. PubMed ID: 16815380
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression following organ transplantation. Part 1: mechanisms and immunosuppressive agents.
Cajanding R
Br J Nurs; 2018 Sep; 27(16):920-927. PubMed ID: 30187798
[TBL] [Abstract][Full Text] [Related]
18. New immunosuppressive agents in pediatric transplantation.
Nguyen C; Shapiro R
Clinics (Sao Paulo); 2014; 69 Suppl 1(Suppl 1):8-16. PubMed ID: 24860853
[TBL] [Abstract][Full Text] [Related]
19. Novel Immunosuppression in Solid Organ Transplantation.
Konda P; Golamari R; Eisen HJ
Handb Exp Pharmacol; 2022; 272():267-285. PubMed ID: 35318509
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive drugs and associated complications in abdominal organ transplantation.
Olson JC
Curr Opin Crit Care; 2022 Apr; 28(2):208-215. PubMed ID: 35142726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
